Neurosurgical procedures for the treatment of Parkinson's disease. Current status;Neurochirurgische Verfahren zur Behandlung des Morbus Parkinson. Eine Bestandsaufnahme

Nervenarzt

Volumn 68, Issue 6, 1997, Pages 466-476

  Diederich, N J ^a   Alesch, F ^b  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b Universitatsklinik fur Neurochirurgie Innsbruck   (Austria)

Author keywords

deep brain stimulation; fetal transplant; pallidotomy; stereotaxy; thalamotomy

Indexed keywords

FETAL TISSUE TRANSPLANTATION; GLOBUS PALLIDUS; HUMAN; NEUROSURGERY; PARKINSON DISEASE; REVIEW; THALAMUS; ANIMAL; BRAIN; BRAIN TRANSPLANTATION; ELECTROSTIMULATION THERAPY; MESENCEPHALON; PATHOPHYSIOLOGY; PHYSIOLOGY; THALAMUS NUCLEUS; TRANSPLANTATION;

DOPAMINE;

ANIMALS; BRAIN; BRAIN TISSUE TRANSPLANTATION; DOPAMINE; ELECTRIC STIMULATION THERAPY; FETAL TISSUE TRANSPLANTATION; GLOBUS PALLIDUS; HUMANS; MESENCEPHALON; PARKINSON DISEASE; THALAMIC NUCLEI;

EID: 0030612316     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050149     Document Type: Review

References (140)

1. Aebischer P, Tresco PA, Sagen J, Winn SR (1991) Transplantation of microencapsulated bovine chromaffin cells reduces lesion-induced rotational asymmetry in rats. Brain Res 560:43-49
2. Aebischer P, Tresco PA, Winn SR, Greene LA et al (1991) Long-term cross-species brain transplantation of a polymer-encapsulated dopamine-secreting cell line. Exp Neurol 111:269-275
3. Albin RL, Young AB, Penney JB (1995) The functional anatomy of disorders of the basal ganglia. TINS 18:63-64
4. Alesch F (1995) Neurochirurgische Verfahren bei Morbus Parkinson. Wien Med Wochenschr 145:305-309
5. Alesch F, Pinter IMM, et al. (1995) Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir (Wien) 136:75-81
6. entfallt
7. Alexander GE, Crutcher MD, DeLong MR (1990) Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res 85:119-146
8. Alexander GE, DeLong MR, Strick L (1986) Parallel organization of functionary segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381
9. Alterman RL, Kall BA, Cohen H, Kelly PJ (1995) Stereotactic ventrolateral thalamotomy: is ventriculography necessary? Neurosurgery 37:717-722
10. Aziz TZ, Peggs D, Sambrook MA, Crossman AR (1991) Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism in the primate. Mov Disord 6:288-292
11. Bakay RAE (1991) Selection criteria for CNS grafting into Parkinson's disease patients. In. Lindvall O, Bjoerkiund A, Widner N (eds) Intracerebral transplantation in movement disorders. Elsevier, Amsterdam New York, pp 137-148
12. Bakay RA, Barrow DL, Fiandaca MS, Iuvone PM et al (1987) Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation. Ann NY Acad Sci 495:623-640
13. Beck KD, Valverde J, Alexi T, Poulsen K et al (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 273 339-341
14. Benabid AL, Pollak P, Gervason C, Hoffmann D et al (1991) Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337:403-406
15. Benabid AL, Pollak P, Louveau A, Henry S et al. (1987) Combined (thalamotomy and stimulation) Stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 50 344-346
16. Berman H, Wichmann T, DeLong MR (1990) Reveral of experimental Parkinsonism by lesions of the subthalamic nucleus. Science 249:1436-1438
17. Bjorklund A, Steveni U (1979) Reconstruction of the nigrostriatal dopamine pathways by intracerebral nigral transplants. Brain Res 77:555-560
18. Blond S, Caparros-Lefebvre D, Parker F, Assker R et al. (1992) Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 77:62-68
19. Brundin P, Nilsson OG, Strecker RE, Lindvall O et al. (1986) Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 65:235-240
20. Brundin P, Strecker RE, Lindvall O, Isacson O et al. (1987) Intracerebral grafting of dopamine neurons. Experimental basis for clinical trials in patients with Parkinson's disease. Ann NY Acad Sci 495:473-495
21. Burchiel KJ (1995) Thalamotomy for movement disorders. Neurosurg Clin N Am 6:55-71
22. Burns RS, Chiueh CC, Markey SP et al. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550
23. Caparros-Lefevre D, Blond S, Vermesch P, Pecheux N et al, (1993) Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry 56:268-273
24. Caparros-Lefebvre D, Ruchoux MM, Blond S, Petit H et al (1994) Long-term thalamic stimulation in Parkinson's disease: postmortem anatomoclinical study. Neurology 44:1856-1860
25. Capit Committee: Langston JW, Widner H, Goetz CG, Brooks D et al. (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7.2-13
26. Ceballos-Baumann AO, Obeso JA, Vitek JL, Delomg MR et al. (1994) Restoration of thalamocortical activity after posteroventral pallidotomy in Parkinson's disease. Lancet 344:814
27. Cooper IS (1953) Ligation of the anterior choroidal artery for involontary movements of parkinsonism. Psychiatr Q 27:317-319
28. Cooper IS (1961) Parkinsonism: its medical and surgical therapy. Thomas, Springfield, III
29. Date Isao, Asari S, Ohmoto T (1995) Two-year follow-up study of a patient with Parkinson's disease and severe motor fluctuations treated by co-grafts of adrenal medulla and peripheral nerve into bilateral caudate nuclei: case report. Neurosurgery 37:515-519
30. Defer GL, Geny C, Ricolfi F, Fenelon G et al. (1996) Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119:41-50
31. Deiber MP, Pollak P, Passingham R, Landais P et al. (1993) Thalamic stimulation and suppression of parkinsonian tremor. Evidence of a cerebellar deactivation using positron emission tomography. Brain 116 267-279
32. Diamond SG, Markham CH, Rand RW, Becker DP et al. (1994) Four-year follow-up of adrenal-to-brain transplants in Parkinsons's disease. Arch Neurol 51 559-563
33. Diederich N, Goetz CG, Stebbins GT, Klawans HL et al (1992) Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomy or subthalamotomy on tremor in Parkinson's disease. Neurology 42:1311-1314
34. Dogali M, Fazzini E, Kolodny E, Eidelberg D et al. (1995) Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 45:753-761
35. During MJ, Freese A, Sabel BA, Saltzman WM et al. (1989) Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol 25:351-356
36. Eidelberg D, Moeller JR, Ishikawa T, Dhawan V et al. (1996) Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 39:450-459
37. Fabre JW (1995) Nudging xenotransplantation towards human. Nat Med 1:403-404
38. Fahn S (1992) Fetal-tissue transplants in Parkinson's disease. N Engl J Med 327 1589-1590
39. Fazzini E, Beric A, Eidelberg D, Dogali M et al. (1995) Two-year follow-up after unilateral pallidotomy in patients with Parkinson's disease. Neurology [Suppl 4] 45:A376
40. Fazzini E, Dogali M, Eidelberg D, Beric A (1996) Three-year follow-up following unilateral pallidotomy in Parkinson's disease. Neurology [Suppl 2] 46:A200
41. Fiandaca MS, Kordower JH, Hansen JT, Hansen JT et al (1988) Adrenal medullary autograft into the basal ganglia of cebus monkeys: injury-induced regeneration. Exp Neurol 102:76-91
42. Folkert R, Durso R (1996) Survival and proliferation of non neural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 46:1219-1225
43. Fox MW, Ahlskog JE, Kelly PJ (1991) Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa aera Parkinson's disease patients. J Neurosurg 75:723-730
44. Freed CR, Breeze RE, Rosenberg NL, Schneck SA et al. (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555
45. Freed WJ, Spoor HE, De Beaurepaire R, Greenberg JA et al (1987) Embryonic substantia nigra grafts. Factors controlling behavioral efficacy and reinnervation of the host striatum. Ann NY Acad Sci 495:581-598
46. Freeman TB, Olanow CW, Hauser RA, Nauert GM et al. (1995) Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379-388
47. Friedman JH, Epstein M, Sanes J, Lieberman P et al. (1996) Gamma knife pallidotomy in advanced Parkinson's disease. Ann Neurol 39 535-538
48. Gage FH, Kawaja MD, Fisher LJ (1991) Genetically modified cells: applications for intracerebral grafting.TINS 14 328-333
49. Gage FH, Wolff JA, Rosenberg MB, Xu L et al. (1987) Grafting genetically modified cells to the brain: possibilities for the future. Neuroscience 23:795-807
50. Ghika J, Favre J, Fankhauser H, Regli F (1996) Neurological and neuropsychological complications of bilateral contemporaneous pallidotomy in Parkinson's disease. Neurology [Suppl 2] 46:A417
51. Goetz CG, DeLong MR, Penn RD, Bakay RE (1993) Neurosurgical horizons in Parkinson's disease. Neurology 43:1-7
52. Goetz CG, Diederich NJ (1993) Neural transplants in Parkinson's disease. In: Koller WC (ed) Handbuch of Parkinson's disease Dekker, New York Basel, pp 545-568
53. Goetz CG, Diederich NJ (1996) Renaissance time for pallidotomy as treatment of Parkinson's disease? Nat Med 2:510-514
54. Goetz CG, Stebbins GT, Klawans HL, Koller WC et al (1991) United Parkinson foundation neurotransplantation registry on adrenal medullary transplantation; presurgical, one-year and two-year follow up. Neurology 41:1719-1722
55. Goldman MS, Ahlskog JE, Kelly PJ (1992) The symptomatic and functional outcome of stereotactic thalamotomy for medically intractable essential tremor. J Neurosurg 76:924-928
56. Grafton ST, Waters C, Sutton J, Lew MF et al. (1995) Pallidotomy increases activity of motor association cortex in Parkinson's disease: a positron emission tomographic study. Ann Neurol 37:776-783
57. Green J, Vitek JL, Baron M, Bakaey RAE et al. (1996) Neuropsychological sequelae of pallidotomy for treatment of Parkinson's disease: one-year pilot findings. Neurology [Suppl 2] 46 A200
58. Greenamyre JT (1996) Pharmacological pallidotomy with glutamate antagonists. Ann Neurol 39:557-558
59. Gundi J, Luquin MR, Herrero MT, Obeso JA (1993) The subthalamic nucleus: a possible target for stereotaxic surgery in Parkinson's disease. Mov Disord 8:421-429
60. Hassler R (1959) Anatomy of the thalamus. In Schaltenbrand G, Bailey P (eds) Introduction to stereotaxis with an atlas of the human brain. Thieme, Stuttgart New York, pp 230-290
61. Hassler R, Riechert T (1954) Indikationen und Lokalisationsmethode der gezierten Hirnoperationen. Nervenarzt 25:441-447
62. Heikkinen E (1986) Stereotactic neurosurgery: new aspects of an old method. Ann Clin Res [Suppl 47] 18:73-83
63. Hitchkock EH, Whitwell HL, Sofroniew MV, Bankiewicz KS (1994) Survival of TH-positive and neuromelanin-containing cells in patients with Parkinson's disease after intrastriatal grafting of fetal ventral mesencephalon. Exp Neurol 129:3
64. Hughes RC, Polgar JG, Weightman D, Walton JN (1971) L-Dopa in Parkinsonism and the influence of previous thalamotomy. BMJ 1:7-13
65. Iacono RP, Shima F, Lonser RR, Kuniyoshi S et al. (1995) The results, indications, and physiology of posteroventral pallidotomy for patients with Parkinson's disease. Neurosurgery 36:1118-1125
66. Ichitani Y, Okamura H, Matsumoto Y, Nagatsu I et al. (1991) Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Res 549 350-353
67. Isacson O, Deacon TW, Pakzaban P, Dinsmore J et al (1995) Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth pattern of glial and axonal fibres. Nat Med 1 1189-1195
68. Jankovic J, Cardaso F, Grossman R, Hamilton W (1995) Outcome after stereotactic thalamotomy for parkinsonian, essential, and other forms of tremor. Neurosurgery 37:680-686
69. Kall BA, Goerss SJ, Kelly PJ (1992) A new multimodality correlative technique for VOP/VIM (VL) thalamotomy procedures. Stereotact Funct Neurosurg 58:45-51
70. Kelly PJ, Ahlskog JE, Goerss SJ, Daube JR et al (1987) Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease. Mayo Clin Proc 62:655-664
71. Kelly PJ, Gillingham J (1983) The long-term results of stereotactic surgery and 1-dopa therapy in patients with Parkinson's disease. A 10-year follow-up study. J Neurosurg 53 332-337
72. Klockgether T, Loeschmann PA, Wuellner U (1995) Neue Ansätze zur medikamentösen Behandlung der Parkinsonschen Krankheit. Akt Neurol 22:217-223
73. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJG et al. (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124
74. Laitinen LV (1985) Brain targets in surgery for Parkinson's disease. Results of a survey of neurosurgeons. J Neurosurg 62:349-351
75. Laitinen LV (1995) Pallidotomy for Parkinson's disease. Neurosurg Clin N Am 6:105-112
76. Laitinen LV, Bergenheim T, Hariz MI (1992) Leksell's posteroventral palidotomy in the treatment of Parkinson's disease. J Neurosurg 76:53-61
77. Langston JW, Ballard P, Tetrud JW et al. (1983) Chronic parkinsonism in humans due to a product of merperidine-analog synthesis. Science 219:979-980
78. Limousin P, Benabid AL, Hoffmann D, Pollak P (1996) Bilateral subthalamic nucleus Stimulation improves motor function in patients with severe Parkinson's disease. Neurology [Suppl 2] 46:A400
79. Limousin P, Pollak P, Benazzouz A, Hoffmann D et al. (1995) Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91-95
80. Limousin P, Pollak P, Hoffmann D, Benazzouz A et al (1996) Abnormal involuntary movements induced by subthalamic nucleus stimulation in Parkinsonian patients. Mov Disord 11:231-235
81. Lindvall O, Backlund EO, Farde L, Sedvall G et al, (1987) Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol 22:457-468
82. Lindvall O, Brundin P, Widner H, Rehncrona S et al. (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577
83. Lindvall O (1991) Prospects of transplantation in human neurodegenerative diseases. TINS 14:376-384
84. Lozano AM, Lang AE, Galvez-Jimenez N, Myasaki J et al.(1995) Effect of GPi pallidotomy on motor function in Parkinson's disease. Lancet 346:1383-1387
85. Madrazo I, Drucker-Colin R, Diaz V, Martinez-Mata J et al. (1987) Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 316:831-334
86. Martin WRW, Perlmutter JS (1994) Assessment of fetal tissue transplantation in Parkinson's disease. Neurology 44:1777-1780
87. Matsumoto K, Shichijo F, Fukami T (1984) Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy. J Neurosurg 60:1033-1044
88. McCurry KR, Kooyman DI, Alvarado CG, Cotterell AH et al. (1995) Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1:423-427
89. Moringlane JR, Alesch F, Gharehbaghi H, Haass A et al. (1995) Chronische Elektrostimulation des Nucleus ventralis intermedius des Thalamus zur Tremorbehandlung. Akt Neurol 22:176-180
90. Morrish PK, Sawle GV, Brooks DJ, Wenning NP et al (1996) Long-term follow-up, by 18F-dopa PET, of ipsilateral and contralateral striatal function after unilateral embryonic mesencephalic implantation in Parkinson's disease. Neurology [Suppl 2] 46:A416
91. Mundinger F, Riechert T (1963) Die stereotaktischen Hirnoperationen zur Behandlung extrapyramidaler Bewegungsstörungen (Parkinsonismus und Hyperkinesen) und ihre Resultate. Fortschr Neurol Psychiatry 31:1-65
92. Mundinger F, Riechert T (1966) Indikationen und Langzeitergebnisse von 1400 uni- und bilateralen stereotaktischen Eingriffen beim Parkinson-Syndrom. Wien Z Nervenheilkd 23 147-170
93. Narabayashi H, Yokochi F, Nakajima Y (1984) Levodopa-induced dyskinesia and thalamotomy. J Neurol Neurosurg Psychiatr 47:831-839
94. Nittner K (1965) The combined thalamo-subthalamotomy. Confin Neurol 32:93-99
95. Nittner Z (1964) Zum heutigen Stand stereotaktischer Hirnoperationen. Dtsch Arztebl 37:1903-1912
96. Oertel WH (1988) Transplantation von Dopamin-synthetisierenden Zellen - eine neue Therapie der Parkinson-Krankheit? Akt Neurol 15 156-100
97. Ohye C (1986) Role des noyaux thalamiques dans l'hypertonie et le tremblement de la maladie de Parkinson. Rev Neurol (Paris) 142:362-367
98. Olanow CW, Kordower JH, Freeman TB (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. TINS 19:102-109
99. Olson L, Backlund EO, Ebendal T, Freedman R et al (1991) Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. Arch Neurol 48 373-381
100. Olson L, Backman L, Ebendal T, Eriksdotter-Jonhagen M et al. (1994) Role of growth factors in degeneration and regeneration in central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer diseases. J Neurol [Suppl 1] 242:12-15
101. Page RD (1992) The use of thalamotomy in the treatment of levodopa-induced dyskinesia. Acta Neurochir (Wien) 114:77-117
102. Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Rev 20:128-154
103. Perlow MJ, Freed WJ, Hoffer BJ et al. (1979) Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine systems. Science 204:643-647
104. Peschanski M, Defer G, N'Guyen JP, Ricolfi F et al. (1994) Bilateral motor improvement and alteration of 1-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of fetal ventral mesencephalon. Brain 117:487-499
105. Plunkett RJ, Weber RJ, Oldfield EH (1988) Stereotactic implantation of dispersed cell suspensions into brain. A systematic appraisal of cell placement and survival. J Neurosurg 69:228-233
106. Pollak P, Benabid AL, Gross C, Gao DM et al. (1993) Effects de la stimulation du noyau sous-thalamique dans la maladie de Parkinson. Rev Neurol (Paris) 149:175-176
107. Redmond DE, Leranth C, Spencer DD et al (1990) Fetal neural graft survival. Lancet 336:820-322
108. Redmond DE, Sladek JR, Roth RH et al. (1986) Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet 1:1125-1127
109. Remy P, Samson Y, Hantraye P, Fontaine A et al. (1995) Clinical correlates of [18F] fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 38.580-588
110. Riechert T (1962) Long term follow-up of results of stereotactic treatment in extrapyramidal disorders. Confin Neurol 22:356-363
111. Rosenstein JM (1995) Why do neural transplants survive? An examination of some metabolic and pathophysiological considerations in neural transplantation. Exp Neurol 133.1-6
112. Sanker P (1985) Ergebnisse stereotaktischer Eingriffe beim Parkinson-Syndrom unter besonderer Berücksichtigung der Krankheitsgenese, der Hauptsymptome und des Koagulationsortes. Med Dissertation, Universitat Koln
113. Sass KJ, Buchanan CP, Westerveld M, Marek KL et al. (1995) General cognitive ability following unilateral and bilateral fetal ventral mesencephalic tissue transplantation for treatment of Parkinson's disease. Arch Neurol 52:680-686
114. Sawle GV, Gloomfield PM, Bjorklund A, Brooks DJ et al. (1992) Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]-1-fluorodopa studies in two patients with putaminal implants. Am Neurol 31:166-173
115. Schaetzl HM (1995) Neurotrophic factors: ready to go? TINS 18:463-464
116. Siegfried J, Lippitz B (1994) Bilateral chronic electrostimulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35:1126-1129
117. Sladek JR, Collier TJ, Haber SN et al. (1987) Reversal of parkinsonism by fetal nerve cell transplants in primate brain. Ann NY Acad Sci 495:641-657
118. Spencer DD, Robbins RJ, Naftolin F, Marek KL et al. (1992) Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548
119. Spiegel EA, Wycis HY, Marks M, Lee AJ (1946) Stereotactic apparatus for operations on the human brain. Science 106:349-350
120. Sterio D, Beric A, Dogali M, Fazzini E et al (1994) Neurophysiological properties of pallidal neurons in Parkinson's disease A. Ann Neurol 35:586-591
121. Strange PG Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Mav Disord 8 263-270
122. Stromberg J, Bygeman M, Geldstein M et al. (1986) Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation. Neurosci Lett 71:271 -276
123. Struppler A, Burg D, Luecking CH, Velho F (1974) The mode of innervation following thalamotomy and subthalamotomy. Confin Neurol 36.347-354
124. Struppler A, Jakob C (1995) Control of muscletone and -force on moto-thalamus level. Neurophysiological investigations. 4th meeting on microelectrode techniques during functional and stereotactic surgery. Wien, May 1995
125. Sutton JB, Couldwell W, Lew MF, Mallory I et al. (1995) Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease. Neurosurgery 36:1112-1117
126. Svendsen CN, Rosser AE (1995) Neurones from stem cells? TINS 18:465-467
127. Svennilson E, Torvik A, Lowe R, Leksell L (1960) Treatment of parkinsonism by stereotactic thermolesions in the pallidal region. A clinical review of 81 cases. Acta Psychtatr Scand 35 358-377
128. Takayama H, Ray J, Raymon HK, Baird A et al (1995) Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat Med 1:53-58
129. Tasker RR (1976) Surgery for Parkinson's disease. In: Morley TP (ed) Current contoversies in neurosurgery. Saunders, Philadelphia, pp 411-418
130. Tasker RR, Kiss ZHT (1995) The role of the thalamus in functional neurosurgery. Neurosurg Clin N Am 6:73-104
131. Tomac A, Lindqvist E, Lin LFH, Ogren SO et al (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339
132. Tsukahara T, Takeda M, Shimohama S, Ohara O et al. (1995) Effects of brain-derived neurotrophicfactor on 1-methyl-4-phenyl-l,2,3,6-tetrahydropyridine-induced Parkinsonism in monkeys. Neurosurgery 37:733-739
133. Ungerstedt U (1968) 6-Hydroxydopamine-induced degeneration of central monoamine neurons. Eur J Pharmacol 5:107-110
134. Wenning GK, Morrish PK, Sawle GV, Qumn NP et al. (1996) Bilateral embryonic mesencephalic grafts in patients with Parkinson's disease: interim analysis of long-term follow-up after unilateral grafting. Neurology [Suppl 2] 46:A416
135. Wester K, Haughe-Hansen E (1990) Stereotactic thalamotomy-experiences from the levodopa era. J Neurol Neurosurg Psychiatry 53 427-430
136. Widner H, Tetrud J, Rehngrona S, Snow B et al. (1992) Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med 327:1556-1563
137. Winn SR, Wahlberg L, Tresco PA, Aebischer P (1991) An encapsulated dopamine-releasing polymer alleviates experimental parkinsonism in rats. Exp Neurol 105:244-250
138. Wu CY, Zhou MD, Bao XF, Zhang QL et al. (1994) The combined method of transplantation of fetal substantia nigra and Stereotactic thalamotomy for Parkinson's disease. Br J Neurosurg 8 709-716
139. Yurek DM, Lu W, Hipkens S, Wiegand S (1996) BONF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp Neurol 137 105-118
140. Young AB (1993) The role of excitatory neurotransmitters in movement disorders. Teaching Courses AAN 243:1-8